Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
In Duchenne, boys begin to show signs of muscle weakness as early as two to five years of age. The disease gradually weakens the skeletal or voluntary muscles in the arms, legs and trunk. Due to progressive muscle weakness, Duchenne patients are often wheelchair bound between the ages of seven and 13 years old. At a later stage, the boys' respiratory and cardiac muscles are also affected and for most boys, respiratory and cardiac failure are major causes of death, often prevalent by the age of 20.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Duchenne Muscular Dystrophy market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Duchenne Muscular Dystrophy market. Detailed analysis of key players, along with key growth strategies adopted by Duchenne Muscular Dystrophy industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Bristol-Myers Squibb
PTC Therapeutics
Others
By Type:
Deflazacort
Prednisone
Others
By End-User:
Male
Female
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Duchenne Muscular Dystrophy Market
-
1.3 Market Segment by Type
-
1.3.1 China Duchenne Muscular Dystrophy Market Size and Growth Rate of Deflazacort from 2016 to 2027
-
1.3.2 China Duchenne Muscular Dystrophy Market Size and Growth Rate of Prednisone from 2016 to 2027
-
1.3.3 China Duchenne Muscular Dystrophy Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Duchenne Muscular Dystrophy Market Size and Growth Rate of Male from 2016 to 2027
-
1.4.2 China Duchenne Muscular Dystrophy Market Size and Growth Rate of Female from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Duchenne Muscular Dystrophy Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Duchenne Muscular Dystrophy by Major Types
-
3.4.1 Market Size and Growth Rate of Deflazacort
-
3.4.2 Market Size and Growth Rate of Prednisone
-
3.4.3 Market Size and Growth Rate of Others
4 Segmentation of Duchenne Muscular Dystrophy Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Duchenne Muscular Dystrophy by Major End-Users
-
4.4.1 Market Size and Growth Rate of Duchenne Muscular Dystrophy in Male
-
4.4.2 Market Size and Growth Rate of Duchenne Muscular Dystrophy in Female
5 Market Analysis by Regions
-
5.1 China Duchenne Muscular Dystrophy Production Analysis by Regions
-
5.2 China Duchenne Muscular Dystrophy Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Duchenne Muscular Dystrophy Landscape Analysis
-
6.1 North China Duchenne Muscular Dystrophy Landscape Analysis by Major Types
-
6.2 North China Duchenne Muscular Dystrophy Landscape Analysis by Major End-Users
7 Central China Duchenne Muscular Dystrophy Landscape Analysis
-
7.1 Central China Duchenne Muscular Dystrophy Landscape Analysis by Major Types
-
7.2 Central China Duchenne Muscular Dystrophy Landscape Analysis by Major End-Users
8 South China Duchenne Muscular Dystrophy Landscape Analysis
-
8.1 South China Duchenne Muscular Dystrophy Landscape Analysis by Major Types
-
8.2 South China Duchenne Muscular Dystrophy Landscape Analysis by Major End-Users
9 East China Duchenne Muscular Dystrophy Landscape Analysis
-
9.1 East China Duchenne Muscular Dystrophy Landscape Analysis by Major Types
-
9.2 East China Duchenne Muscular Dystrophy Landscape Analysis by Major End-Users
10 Northeast China Duchenne Muscular Dystrophy Landscape Analysis
-
10.1 Northeast China Duchenne Muscular Dystrophy Landscape Analysis by Major Types
-
10.2 Northeast China Duchenne Muscular Dystrophy Landscape Analysis by Major End-Users
11 Southwest China Duchenne Muscular Dystrophy Landscape Analysis
-
11.1 Southwest China Duchenne Muscular Dystrophy Landscape Analysis by Major Types
-
11.2 Southwest China Duchenne Muscular Dystrophy Landscape Analysis by Major End-Users
12 Northwest China Duchenne Muscular Dystrophy Landscape Analysis
-
12.1 Northwest China Duchenne Muscular Dystrophy Landscape Analysis by Major Types
-
12.2 Northwest China Duchenne Muscular Dystrophy Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Bristol-Myers Squibb
-
13.1.1 Bristol-Myers Squibb Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 PTC Therapeutics
-
13.2.1 PTC Therapeutics Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Others
-
13.3.1 Others Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Duchenne Muscular Dystrophy Market Size and Growth Rate of Deflazacort from 2016 to 2027
-
Figure China Duchenne Muscular Dystrophy Market Size and Growth Rate of Prednisone from 2016 to 2027
-
Figure China Duchenne Muscular Dystrophy Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Duchenne Muscular Dystrophy Market Size and Growth Rate of Male from 2016 to 2027
-
Figure China Duchenne Muscular Dystrophy Market Size and Growth Rate of Female from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Duchenne Muscular Dystrophy Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Duchenne Muscular Dystrophy
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Duchenne Muscular Dystrophy by Different Types from 2016 to 2027
-
Table Consumption Share of Duchenne Muscular Dystrophy by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Deflazacort
-
Figure Market Size and Growth Rate of Prednisone
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Duchenne Muscular Dystrophy by Different End-Users from 2016 to 2027
-
Table Consumption Share of Duchenne Muscular Dystrophy by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Male
-
Figure Market Size and Growth Rate of Female
-
Table China Duchenne Muscular Dystrophy Production by Regions
-
Table China Duchenne Muscular Dystrophy Production Share by Regions
-
Figure China Duchenne Muscular Dystrophy Production Share by Regions in 2016
-
Figure China Duchenne Muscular Dystrophy Production Share by Regions in 2021
-
Figure China Duchenne Muscular Dystrophy Production Share by Regions in 2027
-
Table China Duchenne Muscular Dystrophy Consumption by Regions
-
Table China Duchenne Muscular Dystrophy Consumption Share by Regions
-
Figure China Duchenne Muscular Dystrophy Consumption Share by Regions in 2016
-
Figure China Duchenne Muscular Dystrophy Consumption Share by Regions in 2021
-
Figure China Duchenne Muscular Dystrophy Consumption Share by Regions in 2027
-
Table North China Duchenne Muscular Dystrophy Consumption by Types from 2016 to 2027
-
Table North China Duchenne Muscular Dystrophy Consumption Share by Types from 2016 to 2027
-
Figure North China Duchenne Muscular Dystrophy Consumption Share by Types in 2016
-
Figure North China Duchenne Muscular Dystrophy Consumption Share by Types in 2021
-
Figure North China Duchenne Muscular Dystrophy Consumption Share by Types in 2027
-
Table North China Duchenne Muscular Dystrophy Consumption by End-Users from 2016 to 2027
-
Table North China Duchenne Muscular Dystrophy Consumption Share by End-Users from 2016 to 2027
-
Figure North China Duchenne Muscular Dystrophy Consumption Share by End-Users in 2016
-
Figure North China Duchenne Muscular Dystrophy Consumption Share by End-Users in 2021
-
Figure North China Duchenne Muscular Dystrophy Consumption Share by End-Users in 2027
-
Table Central China Duchenne Muscular Dystrophy Consumption by Types from 2016 to 2027
-
Table Central China Duchenne Muscular Dystrophy Consumption Share by Types from 2016 to 2027
-
Figure Central China Duchenne Muscular Dystrophy Consumption Share by Types in 2016
-
Figure Central China Duchenne Muscular Dystrophy Consumption Share by Types in 2021
-
Figure Central China Duchenne Muscular Dystrophy Consumption Share by Types in 2027
-
Table Central China Duchenne Muscular Dystrophy Consumption by End-Users from 2016 to 2027
-
Table Central China Duchenne Muscular Dystrophy Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Duchenne Muscular Dystrophy Consumption Share by End-Users in 2016
-
Figure Central China Duchenne Muscular Dystrophy Consumption Share by End-Users in 2021
-
Figure Central China Duchenne Muscular Dystrophy Consumption Share by End-Users in 2027
-
Table South China Duchenne Muscular Dystrophy Consumption by Types from 2016 to 2027
-
Table South China Duchenne Muscular Dystrophy Consumption Share by Types from 2016 to 2027
-
Figure South China Duchenne Muscular Dystrophy Consumption Share by Types in 2016
-
Figure South China Duchenne Muscular Dystrophy Consumption Share by Types in 2021
-
Figure South China Duchenne Muscular Dystrophy Consumption Share by Types in 2027
-
Table South China Duchenne Muscular Dystrophy Consumption by End-Users from 2016 to 2027
-
Table South China Duchenne Muscular Dystrophy Consumption Share by End-Users from 2016 to 2027
-
Figure South China Duchenne Muscular Dystrophy Consumption Share by End-Users in 2016
-
Figure South China Duchenne Muscular Dystrophy Consumption Share by End-Users in 2021
-
Figure South China Duchenne Muscular Dystrophy Consumption Share by End-Users in 2027
-
Table East China Duchenne Muscular Dystrophy Consumption by Types from 2016 to 2027
-
Table East China Duchenne Muscular Dystrophy Consumption Share by Types from 2016 to 2027
-
Figure East China Duchenne Muscular Dystrophy Consumption Share by Types in 2016
-
Figure East China Duchenne Muscular Dystrophy Consumption Share by Types in 2021
-
Figure East China Duchenne Muscular Dystrophy Consumption Share by Types in 2027
-
Table East China Duchenne Muscular Dystrophy Consumption by End-Users from 2016 to 2027
-
Table East China Duchenne Muscular Dystrophy Consumption Share by End-Users from 2016 to 2027
-
Figure East China Duchenne Muscular Dystrophy Consumption Share by End-Users in 2016
-
Figure East China Duchenne Muscular Dystrophy Consumption Share by End-Users in 2021
-
Figure East China Duchenne Muscular Dystrophy Consumption Share by End-Users in 2027
-
Table Northeast China Duchenne Muscular Dystrophy Consumption by Types from 2016 to 2027
-
Table Northeast China Duchenne Muscular Dystrophy Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Duchenne Muscular Dystrophy Consumption Share by Types in 2016
-
Figure Northeast China Duchenne Muscular Dystrophy Consumption Share by Types in 2021
-
Figure Northeast China Duchenne Muscular Dystrophy Consumption Share by Types in 2027
-
Table Northeast China Duchenne Muscular Dystrophy Consumption by End-Users from 2016 to 2027
-
Table Northeast China Duchenne Muscular Dystrophy Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Duchenne Muscular Dystrophy Consumption Share by End-Users in 2016
-
Figure Northeast China Duchenne Muscular Dystrophy Consumption Share by End-Users in 2021
-
Figure Northeast China Duchenne Muscular Dystrophy Consumption Share by End-Users in 2027
-
Table Southwest China Duchenne Muscular Dystrophy Consumption by Types from 2016 to 2027
-
Table Southwest China Duchenne Muscular Dystrophy Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Duchenne Muscular Dystrophy Consumption Share by Types in 2016
-
Figure Southwest China Duchenne Muscular Dystrophy Consumption Share by Types in 2021
-
Figure Southwest China Duchenne Muscular Dystrophy Consumption Share by Types in 2027
-
Table Southwest China Duchenne Muscular Dystrophy Consumption by End-Users from 2016 to 2027
-
Table Southwest China Duchenne Muscular Dystrophy Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Duchenne Muscular Dystrophy Consumption Share by End-Users in 2016
-
Figure Southwest China Duchenne Muscular Dystrophy Consumption Share by End-Users in 2021
-
Figure Southwest China Duchenne Muscular Dystrophy Consumption Share by End-Users in 2027
-
Table Northwest China Duchenne Muscular Dystrophy Consumption by Types from 2016 to 2027
-
Table Northwest China Duchenne Muscular Dystrophy Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Duchenne Muscular Dystrophy Consumption Share by Types in 2016
-
Figure Northwest China Duchenne Muscular Dystrophy Consumption Share by Types in 2021
-
Figure Northwest China Duchenne Muscular Dystrophy Consumption Share by Types in 2027
-
Table Northwest China Duchenne Muscular Dystrophy Consumption by End-Users from 2016 to 2027
-
Table Northwest China Duchenne Muscular Dystrophy Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Duchenne Muscular Dystrophy Consumption Share by End-Users in 2016
-
Figure Northwest China Duchenne Muscular Dystrophy Consumption Share by End-Users in 2021
-
Figure Northwest China Duchenne Muscular Dystrophy Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Bristol-Myers Squibb
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb
-
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb
-
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb
-
Table Product and Service Introduction of Bristol-Myers Squibb
-
Table Company Profile and Development Status of PTC Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of PTC Therapeutics
-
Figure Sales and Growth Rate Analysis of PTC Therapeutics
-
Figure Revenue and Market Share Analysis of PTC Therapeutics
-
Table Product and Service Introduction of PTC Therapeutics
-
Table Company Profile and Development Status of Others
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Others
-
Figure Sales and Growth Rate Analysis of Others
-
Figure Revenue and Market Share Analysis of Others
-
Table Product and Service Introduction of Others
-
